Erratum: Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial with Assessment of Serotonin Transporter Occupancy

被引：0
|
作者：
Henricus G Ruhé
Jan Booij
Henk C v Weert
Johannes B Reitsma
Eric JF Fransen
Martin C Michel
Aart H Schene
机构：
来源：
Neuropsychopharmacology | 2009年 / 34卷 / 4期
关键词：
D O I：
10.1038/npp.2008.213
中图分类号：
学科分类号：
摘要：
Correction to: Neuropsychopharmacology advance online publication, 1 October 2008; doi: 10.1038/npp.2008.148 In this article, published online on 1 October 2008, one author's name is spelled incorrectly; it should have appeared as Eric JF Franssen.
引用
收藏
页码：1088 / 1088
相关论文
共 50 条
  • [1] Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy
    Ruhe, Henricus G.
    Booij, Jan
    Weert, Henk C. V.
    Reitsma, Johannes B.
    Fransen, Eric J. F.
    Michel, Martin C.
    Schene, Aart H.
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (04) : 999 - 1010
  • [2] Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy
    Henricus G Ruhé
    Jan Booij
    Henk C v Weert
    Johannes B Reitsma
    Eric J F Fransen
    Martin C Michel
    Aart H Schene
    Neuropsychopharmacology, 2009, 34 : 999 - 1010
  • [3] Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder
    Ruhe, Henricus G.
    Ooteman, Wendy
    Booij, Jan
    Michel, Martin C.
    Moeton, Martina
    Baas, Frank
    Schene, Aart H.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (01): : 67 - 76
  • [4] Serotonin transporter polymorphism and paroxetine drug respond in major depressive disorder
    Bozina, Nada
    Mihaljevic-Peles, Alma
    Sagud, Marina
    Jakovljevic, Miro
    Sertic, Jadranka
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 788 - 788
  • [5] Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
    Kishi, Taro
    Matsuda, Yuki
    Matsunaga, Shinji
    Moriwaki, Masatsugu
    Otake, Yoichiro
    Akamatsu, Kaku
    Okochi, Tomo
    Hirano, Shigeki
    Funahashi, Toshihiko
    Okuda, Momoko
    Tabuse, Hideaki
    Fujita, Kiyoshi
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 117 - 125
  • [6] Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
    Lundberg, Johan
    Tiger, Mikael
    Landen, Mikael
    Halldin, Christer
    Farde, Lars
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (08): : 1167 - 1172
  • [7] AREA-SPECIFIC OCCUPANCY OF THE SEROTONIN TRANSPORTER BY ESCITALOPRAM AND CITALOPRAM IN MAJOR DEPRESSIVE DISORDER
    Akimova, E.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [8] Pharmacologic treatment of postpartum women with new-onset major depressive disorder: A randomized controlled trial with paroxetine
    Yonkers, Kimberly A.
    Lin, Haiqun
    Howell, Heather B.
    Heath, A. Christopher
    Cohen, Lee S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (04) : 659 - 665
  • [9] A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
    Lapidus, Kyle A. B.
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Soleimani, Laili
    Feder, Adriana
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    BIOLOGICAL PSYCHIATRY, 2014, 76 (12) : 970 - 976
  • [10] Acupuncture for the Treatment of Major Depressive Disorder: A Randomized Controlled Trial
    Andreescu, Carmen
    Glick, Ronald M.
    Emeremni, Chetachi A.
    Houck, Patricia R.
    Mulsant, Benoit H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (08) : 1129 - 1135
12345